Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

C. R. Divgi, S. Welt, M. Kris, F. X. Real, S. D.J. Yeh, R. Gralla, B. Merchant, S. Schweighart, M. Unger, S. M. Larson, J. Mendelsohn

Research output: Contribution to journal › Article › peer-review